European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 145, Issue 1 , Pages 41-44 , July 2009

Adeno-associated virus and human papillomavirus types in cervical samples of pregnant and non-pregnant women

In memory of Jussara P. Nascimento.

  • Luciana B. Freitas

      Affiliations

    • Center of Infectious Diseases, Health Science Center, Federal University of Espírito Santo, Vitória-ES, Brazil
    • Corresponding Author InformationCorresponding author at: Núcleo de Doenças Infecciosas, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo, Av. Marechal Campos 1468, Maruípe, CEP 29041-090, Vitória-ES, Brazil. Tel.: +55 27 8112 1848; fax: +55 27 2122 7210.
    • ,
  • Christiane C. Pereira

      Affiliations

    • Center of Infectious Diseases, Health Science Center, Federal University of Espírito Santo, Vitória-ES, Brazil
    • ,
  • Rita Checon

      Affiliations

    • Center of Infectious Diseases, Health Science Center, Federal University of Espírito Santo, Vitória-ES, Brazil
    • ,
  • José Paulo G. Leite

      Affiliations

    • Laboratory of Comparative Virology, Oswaldo Cruz Institute, Rio de Janeiro-RJ, Brazil
    • ,
  • Jussara P. Nascimento

      Affiliations

    • Department of Microbiology and Parasitology, Biomedical Institute, Fluminense Federal University, Niterói-RJ, Brazil
    • ,
  • Liliana C. Spano

      Affiliations

    • Center of Infectious Diseases, Health Science Center, Federal University of Espírito Santo, Vitória-ES, Brazil
    • Department of Pathology, Health Science Center, Federal University of Espírito Santo, Vitória-ES, Brazil

Received 11 December 2008 ,Revised 27 February 2009 ,Accepted 30 March 2009.

References 

  1. Berns K, Parrish CR. Parvoviridae. In:  Knipe DM,  Howley PM,  Griffin DE,  Lamb RA,  Martin MA,  Roizman B, et al. editor. Fields Virology, Philadelphia. Lippincott Williams & Wilkins; 2007;p. 2437
  2. Schmidt M, Voutetakis A, Afione S, Zheng C, Mandikian D, Chiorini JA. Adeno-associated virus type 12 (AAV12): a Novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent ransduction activity. J Virol. 2008;82:1399–1406
  3. Tobiasch E, Rabreau M, Geletneky K, Larue-Charlus S, Severin F, Becker N. Detection of adeno-associated virus DNA in human genital tissue and in material from spontaneous abortion. J Med Virol. 1994;44:215–222
  4. Erles K, Rohde V, Thaele M, Roth S, Edler L, Schlehofer JR. DNA of adeno-associated virus (AAV) in testicular tissue and in abnormal semen samples. Hum Reprod. 2001;16:2333–2337
  5. Gao G, Vandenberghe LH, Alvira MR, et al. Clades of adeno-associated viruses are widely disseminated in human tissues. J Virol. 2004;78:6381–6388
  6. Kiehl K, Schlehofer JR, Schultz R, Zugaib M, Armbruster-Moraes E. Adeno-associated virus DNA in human gestational trophoblastic disease. Placenta. 2002;23:410–415
  7. Arechavaleta-Velasco FJ, Ma Y, Zhang J, McGrath CM, Parry S. Adeno-associated virus-2 (AAV-2) causes trophoblast dysfunction, and placental AAV-2 infection is associated with preeclampsia. Am J Pathol. 2006;168:1951–1959
  8. Muñoz N, Franceschi S, Bosetti C, et al. Role of parity and human papillomavirus in cervical cancer: The IARC multicentric case-control study. Lancet. 2002;359:1093–1101
  9. Grce M, Husnjak K, Matovina M, et al. Human Papillomavirus, Cytomegalovirus, and adeno-associated Virus infections in pregnant and nonpregnant women with cervical intraepithelial neoplasia. J Clin Microb. 2004;42:1341–1344
  10. You H, Liu Y, Prasad CK, et al. Multiple human papillomavirus genes affect the adeno-associated virus life cycle. Virology. 2006;344:532–540
  11. Hörer M, Weger S, Butz K, Hoppe-Seyler F, Geisen C, Kleinschmidt J. Mutational analysis of adeno-associated virus rep protein-mediated inhibition of heterologous and homologous promoters. J Virol. 1995;69:5485–5496
  12. Walz CM, Correa-Ochoa MM, Müller M, Schlehofer JR. Adeno-associated virus type 2-induced inhibition of the human papillomavirus type 18 promoter in transgenic mice. Virol. 2002;293:172–181
  13. Hermonat PL. Adeno-associated virus inhibits human papillomavirus type 16: A viral interaction implicated in cervical cancer. Can Res. 1994;54:2278–2281
  14. Strickler HD, Viscidi R, Escoffery C, et al. Adeno-associated virus and development of cervical neoplasia. J Med Virol. 1999;59:60–65
  15. Tobiasch F, Burguete T, Klein-Bauernschmitt P, Heilbronn R, Schlehofer JR. Discrimination between different types of human adeno-associated viruses in clinical samples by PCR. J Virol Methods. 1998;71:17–25
  16. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells. 1989;7:209–214
  17. Oliveira LHS, Rodrigues EVM, Lopes APTS, Fernandes AP, Cavalcanti SMB. HPV 16 detections in cervical lesions, physical state of viral DNA and changes in p53 gene. São Paulo Med J. 2003;121:67–71
  18. Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer. 1994;69:167–171
  19. Bernard HU, Chan SY, Manos MM, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence and phylogenetic algorithms. J Infect Dis. 1994;170:1077–1085
  20. Han L, Parmley TH, Keith S, Kozlowski KJ, Smith LJ, Hermonat PL. High prevalence of adeno-associated virus (AAV) type 2 rep DNA in cervical materials: AAV may be sexually transmitted. Virus Genes. 1996;12:47–52
  21. Erles K, Sebokova P, Schlehofer JR. Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). J Med Virol. 1999;59:406–411
  22. Hyun-Sun J, Heung-Jae C, Byung-Hun K, et al. Correlation of human papillomavirus and adeno-associated virus 2 infection in cytology with Korean women. Int J Gynecol Cancer. 2006;16:604–609
  23. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–265
  24. Rama CH, Roteli-Martins CM, Derchain SFM, et al. Prevalence of genital HPV infection among women screened for cervical cancer. Rev Saúde Pública. 2008;42:2–7
  25. Fife KH, Katz BP, Brizendine EJ, Brown DR. Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period. Am J Obstet Gynecol. 1999;80:1110–1114
  26. Hernández-Girón C, Smith JS, Lorincz A, Lazcano E, Hernández-Avila M, Salmerón J. High-risk human papillomavirus detection and related risk factors among pregnant and nonpregnant women in Mexico. Sex Transm Dis. 2005;32:613–618
  27. Spano LC, Gatti J, Nascimento JP, Leite JP. Prevalence of human cytomegalovirus infection in pregnant and non-pregnant women. J Infect. 2004;48:213–220
  28. Smith JS, Robinson NJ. Age specific prevalence on infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis. 2002;186:S3–28
  29. Oliveira SA, Turner DJ, Knowles W, Nascimento JP, Brown DWG, Ward KN. Primary human herpesvirus-6 and -7 infections, often coinciding, misdiagnosed as measles in children from a tropical region of Brazil. Epidemiol Infect. 2003;130:1–7
  30. Burguete T, Rabreau M, Fontanges-Darriet M, et al. Evidence for infection of the human embryo with adeno-associated virus in pregnancy. Hum Reprod. 1999;14:2396–2401

PII: S0301-2115(09)00249-8

doi: 10.1016/j.ejogrb.2009.03.024

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 145, Issue 1 , Pages 41-44 , July 2009

Article Tools